By Lina carolina 
The global landscape of cancer is undergoing a seismic shift, with new diagnoses and fatalities escalating at an alarming rate over the past three decades. A comprehensive new analysis, published in The Lancet, reveals a doubling of new cancer cases since 1990, reaching an estimated 18.5 million in 2023. This surge is accompanied by a 74 percent increase in annual cancer deaths, totaling 10.4 million in the same year, excluding non-melanoma skin cancers. The burden of this escalating disease is increasingly concentrated in low- and middle-income countries (LMICs), where access to resources and healthcare infrastructure often lags behind the rising tide of diagnoses.
The alarming trajectory of cancer incidence and mortality underscores a critical juncture for global health policy. Researchers project that without concerted intervention, new cancer cases will soar by an additional 61 percent over the next 25 years, reaching a staggering 30.5 million annually by 2050. Concurrently, cancer deaths are forecast to surge by nearly 75 percent, claiming 18.6 million lives each year. These projections are largely attributed to demographic shifts, namely population growth and an aging global population, which inherently increases cancer risk.
A Stark Reality: The Growing Global Cancer Burden
The latest findings from the Global Burden of Disease Study Cancer Collaborators paint a sobering picture. Between 1990 and 2023, the number of new cancer cases worldwide more than doubled. This significant increase, reaching 18.5 million new diagnoses in 2023, signifies a growing challenge for healthcare systems globally. The accompanying rise in cancer deaths to 10.4 million annually highlights the mortality associated with these diagnoses.
Crucially, the study emphasizes that the progress in reducing age-adjusted global cancer death rates, which has seen a 24 percent decline between 1990 and 2023, has not been uniform. While high- and upper-middle-income countries have experienced these improvements, many low- and middle-income nations are witnessing both an increase in the absolute number of cancer deaths and a rise in age-standardized mortality rates. This disparity is particularly concerning, as it suggests that the most vulnerable populations are bearing a disproportionate share of the escalating cancer burden.
The Preventable Core: Modifiable Risk Factors and Missed Opportunities
A central and perhaps most actionable finding of the study is the identification of preventable causes as significant drivers of cancer deaths. Over 40 percent of all cancer deaths worldwide are linked to 44 modifiable risk factors. These include well-established culprits such as tobacco use, unhealthy diets, high blood sugar, obesity, alcohol consumption, and environmental exposures like air pollution. This statistic presents a powerful argument for prioritizing robust prevention strategies as a cornerstone of global cancer control efforts.
Tobacco use alone stands out as a leading contributor, accounting for approximately 21 percent of all cancer deaths globally. Its impact is felt across all income levels, though its role as the primary risk factor varies. In LMICs, unsafe sex emerged as the leading risk factor, linked to 12.5 percent of cancer deaths, highlighting the interconnectedness of infectious diseases and cancer development in certain regions.
The study also revealed gender-specific patterns in risk factor attribution. In 2023, a greater proportion of cancer deaths in men (46 percent) were linked to modifiable risks, including tobacco, unhealthy diet, and high alcohol consumption. For women, 36 percent of cancer deaths were associated with factors such as tobacco, unsafe sex, unhealthy diet, obesity, and high blood sugar. These insights are crucial for tailoring targeted prevention campaigns and interventions.
Projected Crisis: A Forecast of Escalating Numbers
Looking ahead, the projections for the coming decades are stark. By 2050, the global cancer burden is expected to intensify dramatically. Researchers anticipate that 30.5 million new cancer cases will be diagnosed annually, and 18.6 million individuals will succumb to the disease. The study’s authors highlight that more than half of these new cases and nearly two-thirds of the projected deaths are expected to occur in LMICs. This forecast underscores the urgent need for increased investment in healthcare infrastructure, diagnostic capabilities, and treatment access in these regions.
Despite the anticipated rise in absolute numbers, the age-adjusted incidence and mortality rates are not expected to increase globally. This suggests that the primary driver of the growing cancer burden will be demographic shifts, particularly the aging of the population, rather than a worsening of individual risk factors on a global scale. However, this nuanced point does not diminish the urgency of addressing modifiable risks, as these remain critical in preventing a substantial portion of cancers.
The projected increase in cancer cases and deaths between 2024 and 2050 falls significantly short of the United Nations Sustainable Development Goal (SDG) target to reduce premature deaths from non-communicable diseases, including cancer, by one-third by 2030. This gap signifies a considerable challenge in achieving global health objectives and necessitates a more ambitious and coordinated approach.
Expert Calls for Urgent Global Action and Equitable Solutions
The findings have prompted strong calls from leading researchers and public health advocates for immediate and intensified global action. Dr. Lisa Force, lead author of the study from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, articulated the gravity of the situation. "Cancer remains an important contributor to disease burden globally, and our study highlights how it is anticipated to grow substantially over the coming decades, with disproportionate growth in countries with limited resources," she stated. "Despite the clear need for action, cancer control policies and implementation remain underprioritized in global health, and there is insufficient funding to address this challenge in many settings."
Dr. Force further emphasized the critical need for equitable access to care. "Ensuring equitable cancer outcomes globally will require greater efforts to reduce disparities in health service delivery such as access to accurate and timely diagnosis, and quality treatment and supportive care," she added.
The analysis, which draws on an extensive dataset encompassing population-based cancer registries, vital registration systems, and interviews with caregivers, provides detailed estimates for 204 countries and territories from 1990 to 2023, examining 47 cancer types and 44 attributable risk factors. This comprehensive approach allows for a granular understanding of the cancer burden and its drivers at various levels.
Disparities in Cancer Burden: A Tale of Two Worlds
The uneven distribution of the cancer burden is a recurring theme throughout the study. While the global age-standardized cancer death rate has declined, this progress is largely concentrated in wealthier nations. In contrast, low-income countries have seen a concerning 24 percent increase in age-standardized cancer incidence, and lower-middle-income countries have experienced a 29 percent rise. This trend starkly illustrates the growing disparities in regions with fewer resources, where the capacity to prevent, detect, and treat cancer is often limited.
Geographically, the study identified specific countries with significant shifts in cancer incidence and mortality rates. Lebanon, for instance, recorded the largest percentage increase in age-standardized cancer incidence and mortality rates for both sexes combined between 1990 and 2023. Conversely, the United Arab Emirates saw the greatest decline in age-standardized incidence, while Kazakhstan experienced the largest decrease in age-standardized death rates over the same period. These variations underscore the complex interplay of genetic, environmental, and socioeconomic factors influencing cancer trends.
Globally, breast cancer remained the most commonly diagnosed cancer in 2023 for both sexes combined. Tracheal, bronchus, and lung (TBL) cancer, however, continued to be the leading cause of cancer-related deaths worldwide, highlighting the persistent challenge posed by this often preventable malignancy.
Leveraging Prevention: A Pathway to Saving Lives
The identification of modifiable risk factors presents a critical pathway for mitigating the projected rise in cancer cases and deaths. With 42 percent of cancer deaths in 2023 attributable to these factors, there is a significant opportunity to prevent a substantial number of new diagnoses and save millions of lives.
Dr. Theo Vos, a co-author from IHME, underscored this potential. "With four in 10 cancer deaths linked to established risk factors, including tobacco, poor diet, and high blood sugar, there are tremendous opportunities for countries to target these risk factors, potentially preventing cases of cancer and saving lives, alongside improving accurate and early diagnosis and treatment to support individuals who develop cancer," he stated. "Reducing the burden of cancer across countries and worldwide demands both individual action and effective population-level approaches to reduce exposure to known risks."
This sentiment was echoed by Dr. Meghnath Dhimal from the Nepal Health Research Council, who described the rise of cancer in LMICs as an "impending disaster." He stressed that cost-effective interventions for cancer exist and that an interdisciplinary approach, coupled with multi-sectoral collaboration, is urgently needed to control the growth of non-communicable diseases in these regions.
Equity and Data: Pillars of Future Cancer Control
The researchers strongly advocate for integrating cancer prevention into health policies in LMICs and ensuring equitable cancer control efforts. This means not only focusing on prevention but also guaranteeing timely and effective care for all patients, regardless of their socioeconomic status or geographic location.
Dr. Force highlighted the role of the study’s findings in informing future policy. "These new estimates and forecasts can support governments and the global health community in developing data-informed policies and actions to improve cancer control and outcomes around the world," she explained. "They can also support tracking of progress towards global and regional cancer targets."
A crucial recommendation arising from the analysis is the need for improved data collection, particularly in resource-limited settings. Strengthening cancer surveillance systems through robust cancer and vital registries is deemed essential for a more accurate understanding of the global cancer burden and for informing localized and global strategies.
Acknowledging Limitations and Charting the Path Forward
The authors acknowledge the inherent limitations of their study, primarily the reliance on available data, which can be constrained by gaps in high-quality cancer information, especially in resource-limited countries. Furthermore, current estimates do not fully account for certain infectious diseases known to increase cancer risk in specific lower-income regions, such as Helicobacter Pylori and Schistosoma haematobium, which could lead to an underestimation of cancer deaths linked to modifiable risks.
The projections also do not incorporate the potential impact of recent global events like the COVID-19 pandemic, ongoing conflicts, or future medical breakthroughs, all of which could significantly alter cancer trends.
In a commentary accompanying the study, Dr. Qingwei Luo and Dr. David P Smith from The University of Sydney and Cancer Council NSW, who were not involved in the research, emphasized the imperative for decisive action. "To ensure meaningful progress in reducing the global cancer burden, it is imperative that governments prioritize funding, strengthen health systems, reduce inequalities, and invest in robust cancer control initiatives and research on prevention, intervention, and implementation," they wrote. "Because the future of cancer control depends on decisive, collective action today."
The study, funded by the Gates Foundation, St Jude Children’s Research Hospital, and St Baldrick’s Foundation, serves as a critical call to action, urging a global reevaluation of priorities and a unified commitment to combating the escalating cancer crisis through prevention, early detection, and equitable access to care.
